Human immunodeficiency virus type 1-infected monocytic cells can destroy human neural cells after cell-to-cell adhesion.

PubWeight™: 2.04‹?› | Rank: Top 2%

🔗 View Article (PMID 1303631)

Published in Ann Neurol on July 01, 1992

Authors

M Tardieu1, C Héry, S Peudenier, O Boespflug, L Montagnier

Author Affiliations

1: Laboratoire de Neurovirologie, INSERM Unité 56, Hôpital Bicêtre, Le Kremlin-Bicêtre, France.

Articles citing this

Pathogenesis of human immunodeficiency virus infection. Microbiol Rev (1993) 5.88

Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease. J Exp Med (1992) 2.48

Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis. Am J Pathol (1999) 2.07

Identification of a human immunodeficiency virus type 1 Tat epitope that is neuroexcitatory and neurotoxic. J Virol (1996) 1.78

Human immunodeficiency virus type 1 (HIV-1) tat induces nitric-oxide synthase in human astroglia. J Biol Chem (2002) 1.73

Platelet-activating factor: a candidate human immunodeficiency virus type 1-induced neurotoxin. J Virol (1994) 1.56

Morphine causes rapid increases in glial activation and neuronal injury in the striatum of inducible HIV-1 Tat transgenic mice. Glia (2008) 1.42

Chemokine and chemokine-receptor expression in human glial elements: induction by the HIV protein, Tat, and chemokine autoregulation. Am J Pathol (2000) 1.33

HIV-1 Tat activates neuronal ryanodine receptors with rapid induction of the unfolded protein response and mitochondrial hyperpolarization. PLoS One (2008) 1.23

NADPH oxidase drives cytokine and neurotoxin release from microglia and macrophages in response to HIV-Tat. Antioxid Redox Signal (2009) 1.10

Cell-specific actions of HIV-Tat and morphine on opioid receptor expression in glia. J Neurosci Res (2008) 1.09

Human immunodeficiency virus type 1 subtype C Tat fails to induce intracellular calcium flux and induces reduced tumor necrosis factor production from monocytes. J Virol (2007) 1.07

HIV-infected macrophages mediate neuronal apoptosis through mitochondrial glutaminase. J Neurochem (2007) 1.04

Neurocytopathic effects of beta-amyloid-stimulated monocytes: a potential mechanism for central nervous system damage in Alzheimer disease. Proc Natl Acad Sci U S A (1996) 0.98

Preferential vulnerability of astroglia and glial precursors to combined opioid and HIV-1 Tat exposure in vitro. Eur J Neurosci (2004) 0.98

Effect of 3'-azido-3'-deoxythymidine on human immunodeficiency virus type 1 replication in human fetal brain macrophages. Antimicrob Agents Chemother (1993) 0.95

Attenuated neurotoxicity of the transactivation-defective HIV-1 Tat protein in hippocampal cell cultures. Exp Neurol (2009) 0.94

Human immunodeficiency virus-infected macrophages, gp120, and N-methyl-D-aspartate receptor-mediated neurotoxicity. Ann Neurol (1993) 0.93

Neuronal survival and resistance to HIV-1 Tat toxicity in the primary culture of rat fetal neurons. Exp Neurol (2008) 0.93

Evidence that Par-4 participates in the pathogenesis of HIV encephalitis. Am J Pathol (1999) 0.90

Differential induction of rat neuronal excitotoxic cell death by human immunodeficiency virus type 1 clade B and C tat proteins. AIDS Res Hum Retroviruses (2010) 0.89

Inhibition of Tat-mediated HIV-1 replication and neurotoxicity by novel GSK3-beta inhibitors. Virology (2011) 0.88

Methamphetamine abuse, HIV infection, and neurotoxicity. Int J Physiol Pathophysiol Pharmacol (2009) 0.87

HIV Associated Neurocognitive Disorders. Infect Dis Rep (2013) 0.84

Lentiviral vector-mediated stable expression of sTNFR-Fc in human macrophage and neuronal cells as a potential therapy for neuroAIDS. J Neuroinflammation (2011) 0.83

Direct effects of HIV-1 Tat on excitability and survival of primary dorsal root ganglion neurons: possible contribution to HIV-1-associated pain. PLoS One (2011) 0.83

Protection of human cerebral neurons from neurodegenerative insults by gene delivery of soluble tumor necrosis factor p75 receptor. Exp Brain Res (2005) 0.82

Tat-induced histopathological alterations mediate hippocampus-associated behavioural impairments in rats. Behav Brain Funct (2015) 0.80

The inhibition of microRNAs by HIV-1 Tat suppresses beta catenin activity in astrocytes. Retrovirology (2016) 0.75

Menin mediates Tat-induced neuronal apoptosis in brain frontal cortex of SIV-infected macaques and in Tat-treated cells. Oncotarget (2017) 0.75

Chronic low-level expression of HIV-1 Tat promotes a neurodegenerative phenotype with aging. Sci Rep (2017) 0.75

Articles by these authors

(truncated to the top 100)

Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science (1983) 43.61

T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature (1985) 21.57

Genome organization and transactivation of the human immunodeficiency virus type 2. Nature (1987) 11.79

Genetic variability of the AIDS virus: nucleotide sequence analysis of two isolates from African patients. Cell (1986) 9.01

HIV-1 genome nuclear import is mediated by a central DNA flap. Cell (2000) 5.87

Changes in growth properties on passage in tissue culture of viruses derived from infectious molecular clones of HIV-1LAI, HIV-1MAL, and HIV-1ELI. Virology (1991) 5.54

HIV F/3' orf encodes a phosphorylated GTP-binding protein resembling an oncogene product. Nature (1987) 5.45

Single amino-acid changes in HIV envelope affect viral tropism and receptor binding. Nature (1989) 5.12

Human immunodeficiency viruses. Science (1986) 4.34

Adaptation of lymphadenopathy associated virus (LAV) to replication in EBV-transformed B lymphoblastoid cell lines. Science (1984) 4.02

Inactivation of lymphadenopathy-associated virus by heat, gamma rays, and ultraviolet light. Lancet (1985) 3.27

Human immunodeficiency virus-specific cytotoxic responses of seropositive individuals: distinct types of effector cells mediate killing of targets expressing gag and env proteins. J Virol (1989) 3.05

Programmed cell death in peripheral lymphocytes from HIV-infected persons: increased susceptibility to apoptosis of CD4 and CD8 T cells correlates with lymphocyte activation and with disease progression. J Immunol (1996) 3.05

A possible subunit structure of Rous sarcoma virus RNA. J Gen Virol (1969) 2.96

Simian immunodeficiency virus replicates to high levels in sooty mangabeys without inducing disease. J Virol (1998) 2.94

Molecular cloning and polymorphism of the human immune deficiency virus type 2. Nature (1987) 2.86

Apoptosis in AIDS. Science (1993) 2.86

The specificity of the human immunodeficiency virus type 2 transactivator is different from that of human immunodeficiency virus type 1. EMBO J (1987) 2.85

HIV/HTLV gene nomenclature. Nature (1988) 2.72

Detection of IgG antibodies to lymphadenopathy-associated virus in patients with AIDS or lymphadenopathy syndrome. Lancet (1984) 2.56

VPX mutants of HIV-2 are infectious in established cell lines but display a severe defect in peripheral blood lymphocytes. EMBO J (1989) 2.45

The cytopathic effect of HIV is associated with apoptosis. Virology (1991) 2.43

The human and simian immunodeficiency viruses HIV-1, HIV-2 and SIV interact with similar epitopes on their cellular receptor, the CD4 molecule. AIDS (1988) 2.35

HIV-1-resistance phenotype conferred by combination of two separate inherited mutations of CCR5 gene. Lancet (1998) 2.32

Human immunodeficiency virus type 2 infection associated with AIDS in West Africa. N Engl J Med (1987) 2.32

Programmed cell death in AIDS-related HIV and SIV infections. AIDS Res Hum Retroviruses (1993) 2.29

Identification and antigenicity of the major envelope glycoprotein of lymphadenopathy-associated virus. Virology (1985) 2.23

Molecular cloning of lymphadenopathy-associated virus. Nature (1985) 2.22

Inactivation of lymphadenopathy associated virus by chemical disinfectants. Lancet (1984) 2.19

Effects of mutations in hyperconserved regions of the extracellular glycoprotein of human immunodeficiency virus type 1 on receptor binding. J Virol (1989) 1.97

Prevalence of antibodies to lymphadenopathy-associated retrovirus in African patients with AIDS. Science (1984) 1.95

[Presence of a double chain ribonucleic acid in animal cells]. C R Acad Sci Hebd Seances Acad Sci D (1968) 1.94

Characterization of the RNA dependent DNA polymerase of a new human T-lymphotropic retrovirus (lymphadenopathy associated virus). Biochem Biophys Res Commun (1984) 1.94

Characterization of human immunodeficiency virus type 2 envelope glycoproteins: dimerization of the glycoprotein precursor during processing. J Virol (1989) 1.93

Virus excretion in the cervicovaginal secretions of pregnant and nonpregnant HIV-infected women. J Acquir Immune Defic Syndr (1993) 1.91

A microtransfection method using the luciferase-encoding reporter gene for the assay of human immunodeficiency virus LTR promoter activity. Gene (1990) 1.90

Improved antigenicity of the HIV env protein by cleavage site removal. Protein Eng (1988) 1.87

Inactivation, by UV-, x-, and gamma-radiations, of the infecting and transforming capacities of polyoma virus. Virology (1967) 1.86

A rapid and simple colorimetric test for the study of anti-HIV agents. AIDS Res Hum Retroviruses (1988) 1.80

The multitude and diversity of environmental carcinogens. Environ Res (2007) 1.73

Antibodies to the core protein of lymphadenopathy-associated virus (LAV) in patients with AIDS. Science (1984) 1.73

AIDS in 1988. Sci Am (1988) 1.71

Antimoniotungstate (HPA 23) treatment of three patients with AIDS and one with prodrome. Lancet (1985) 1.70

Increased nuclease activity in cells treated with pppA2'p5'A2'p5' A. Proc Natl Acad Sci U S A (1979) 1.66

Concomitant infection by human herpesvirus 6, HTLV-I, and HIV-2. Lancet (1988) 1.66

Autoantibodies typical of non-organ-specific autoimmune diseases in HIV-seropositive patients. AIDS (1992) 1.65

Establishment of human microglial cell lines after transfection of primary cultures of embryonic microglial cells with the SV40 large T antigen. Neurosci Lett (1995) 1.63

Absence of antibodies to AIDS virus in haemophiliacs treated with heat-treated Factor VIII concentrate. Lancet (1985) 1.60

Acute neuropathy coincident with seroconversion for anti-LAV/HTLV-III. Lancet (1986) 1.58

Advanced breast cancer incidence following population-based mammographic screening. Ann Oncol (2011) 1.53

Lymphadenopathy-associated viral antibody in AIDS. Immune correlations and definition of a carrier state. N Engl J Med (1984) 1.51

Deficient LAV1 neutralising capacity of sera from patients with AIDS or related syndromes. Lancet (1985) 1.48

Isolation and envelope sequence of a highly divergent HIV-1 isolate: definition of a new HIV-1 group. Virology (1994) 1.46

Neuronal apoptosis does not correlate with dementia in HIV infection but is related to microglial activation and axonal damage. Neuropathol Appl Neurobiol (1999) 1.43

Early viral replication in the brain of SIV-infected rhesus monkeys. Am J Pathol (1991) 1.42

Detection of primary cytotoxic T lymphocytes specific for the envelope glycoprotein of HIV-1 by deletion of the env amino-terminal signal sequence. Eur J Immunol (1990) 1.40

Large-scale deletion and point mutations of the nuclear NDUFV1 and NDUFS1 genes in mitochondrial complex I deficiency. Am J Hum Genet (2001) 1.36

AIDS-associated mycoplasmas. Annu Rev Microbiol (1994) 1.34

Variable course of primary simian immunodeficiency virus infection in lymph nodes: relation to disease progression. J Virol (1994) 1.33

Interferon messenger RNA: translation in heterologous cells. Proc Natl Acad Sci U S A (1972) 1.32

Loss of CD4 membrane expression and CD4 mRNA during acute human immunodeficiency virus replication. J Exp Med (1988) 1.31

Lifestyle-related factors and environmental agents causing cancer: an overview. Biomed Pharmacother (2007) 1.29

Biosynthesis of mouse interferon by translation of its messenger RNA in a cell-free system. Proc Natl Acad Sci U S A (1975) 1.27

Human microglial cells: characterization in cerebral tissue and in primary culture, and study of their susceptibility to HIV-1 infection. Ann Neurol (1991) 1.26

Molecular evidence for nosocomial transmission of human immunodeficiency virus from a surgeon to one of his patients. J Virol (1998) 1.26

Transmembrane envelope glycoproteins of human immunodeficiency virus type 2 and simian immunodeficiency virus SIV-mac exist as homodimers. J Virol (1990) 1.26

A monoclonal antibody against LAV gag precursor: use for viral protein analysis and antigenic expression in infected cells. J Immunol (1986) 1.25

Kaposi's sarcoma and new herpesvirus. Lancet (1995) 1.24

Homology of double stranded RNA from rat liver cells with cellular genome. Nat New Biol (1971) 1.22

The relationship between the interferon alpha response and viral burden in primary SIV infection. AIDS Res Hum Retroviruses (1996) 1.21

Direct and indirect mechanisms mediating apoptosis during HIV infection: contribution to in vivo CD4 T cell depletion. Semin Immunol (1993) 1.20

Characterization of an HIV-2-related virus with a smaller sized extracellular envelope glycoprotein. Virology (1989) 1.20

Role of mycoplasma infection in the cytopathic effect induced by human immunodeficiency virus type 1 in infected cell lines. Infect Immun (1992) 1.20

Role of N-linked glycans in the interaction between the envelope glycoprotein of human immunodeficiency virus and its CD4 cellular receptor. Structural enzymatic analysis. J Exp Med (1989) 1.20

Neonatal susceptibility to MHV3 infection in mice. II. Role of natural effector marrow cells in transfer of resistance. J Immunol (1980) 1.17

HIV-2 antisera cross-neutralize HIV-1. AIDS (1988) 1.17

Efficiency of poly(A).poly(U) as an adjuvant. Immunol Today (1988) 1.14

Cell surface expression of several species of human immunodeficiency virus type 1 major core protein. J Virol (1989) 1.14

Programmed cell death as a mechanism of CD4 and CD8 T cell deletion in AIDS. Molecular control and effect of highly active anti-retroviral therapy. Ann N Y Acad Sci (1999) 1.14

Influence of microbial infections on the progression of HIV disease. Trends Microbiol (1997) 1.14

Limited viral spread and rapid immune response in lymph nodes of macaques inoculated with attenuated simian immunodeficiency virus. Virology (1995) 1.13

Longitudinal study of 18 children with perinatal LAV/HTLV III infection: attempt at prognostic evaluation. J Pediatr (1986) 1.13

The chronology of AIDS research. Nature (1987) 1.12

Transmission of lymphadenopathy-associated virus/human T lymphotropic virus type III in sexual partners. Seropositivity does not predict infectivity in all cases. Am J Med (1986) 1.11

What to call the AIDS virus? Nature (1986) 1.11

A study of seroprevalence of HIV-1 and HIV-2 in six provinces of People's Republic of Angola: clues to the spread of HIV infection. J Acquir Immune Defic Syndr (1990) 1.10

The resistance of HIV-infected chimpanzees to progression to AIDS correlates with absence of HIV-related T-cell dysfunction. J Med Primatol (1993) 1.10

Purification and characterization of Mycoplasma penetrans Ca2+/Mg2+-dependent endonuclease. J Bacteriol (1997) 1.10

Cerebral white matter disease in children may be caused by mitochondrial respiratory chain deficiency. J Pediatr (2000) 1.09

High prevalence of lymphadenopathy virus (LAV) in European haemophiliacs. Lancet (1984) 1.09

Two forms of mouse interferon messenger RNA. Biochem Biophys Res Commun (1974) 1.09

Effect of interferon-alpha 1 from E. coli on some cell functions. Science (1980) 1.08

Selective depletion of low-density CD8+, CD16+ lymphocytes during HIV infection. AIDS Res Hum Retroviruses (1988) 1.08

Isotypic restriction of the antibody response to human immunodeficiency virus. AIDS Res Hum Retroviruses (1988) 1.07

Early stages of simian immunodeficiency virus infection in lymph nodes. Evidence for high viral load and successive populations of target cells. Am J Pathol (1994) 1.07

Genetic differences accounting for evolution and pathogenicity of simian immunodeficiency virus from a sooty mangabey monkey after cross-species transmission to a pig-tailed macaque. J Virol (1992) 1.06

Antigenic and genetic differentiation of the two putative types of human herpes virus 6. J Virol Methods (1993) 1.06

[Demonstration of an engagement process towards cell death by apoptosis in lymphocytes of HIV infected patients]. C R Acad Sci III (1991) 1.06

Development of a selective and sensitive polymerase chain reaction assay for the detection of Mycoplasma pirum. FEMS Microbiol Lett (1993) 1.06

HIV-1 core proteins expressed from recombinant vaccinia viruses. AIDS Res Hum Retroviruses (1989) 1.06